Surgical management of Novacor drive-line exit site infections

Ann Thorac Surg. 2002 Oct;74(4):1267-8. doi: 10.1016/s0003-4975(02)03752-9.

Abstract

Implantable left ventricular assist device (LVAD) drive-line exit site infection, an expected consequence of currently available device use, continues to be a significant limiting factor in long-term support. We theorize that the mechanism behind the establishment of the most chronic exit site infections involves a shearing torsion injury that disrupts the tissue adherence interface with the drive-line. The resulting neo-epithelialized drainage tract prevents permanent clearance of the infection with antibiotics alone. The proposed treatment strategy of established infections involves aggressive surgical excision of the involved exit site.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Heart-Assist Devices / adverse effects*
  • Humans
  • Prosthesis-Related Infections / surgery*

Substances

  • Anti-Bacterial Agents